Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen spinoff Atara cranks its Series B up to $52M
Amgen spinoff Atara cranks its Series B up to $52M
Amgen spinoff Atara cranks its Series B up to $52M
Submitted by
admin
on January 10, 2014 - 6:58pm
Source:
Fierce Biotech
News Tags:
Amgen
Atara
Series B
oncology
kidney disease
Headline:
Amgen spinoff Atara cranks its Series B up to $52M
Do Not Allow Advertisers to Use My Personal information
